Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:16 AM
Ignite Modification Date:
2025-12-25 @ 1:16 AM
NCT ID:
NCT00516893
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of a relapsing form of MS
* Must fall within the therapeutic indications stated in the locally approved label for natalizumab
* Other protocol-defined inclusion criteria may apply
Exclusion Criteria:
* Prior treatment with natalizumab
* Considered by investigator to be immunocompromised
* Other protocol-defined exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT00516893
Study Brief:
Protocol Section:
NCT00516893